Anterix CLO exercises options, sells shares
Anterix Inc. Chief Legal Officer & Corporate Secretary Gena L. Ashe exercised stock options and sold common stock in a series of transactions dated June 15, 2026.
Rhea-AI Filing Summary
Anterix Inc. Chief Legal Officer & Corporate Secretary Gena L. Ashe exercised stock options and sold common stock in a series of transactions dated June 15, 2026. She exercised options covering 29,368 shares of common stock at strike prices of $34.96 and $49.39 per share.
To pay the exercise prices and related taxes on a cashless basis, the issuer withheld a total of 15,657 shares at $82.50 per share, which the filing clarifies did not involve open‑market sales. Ashe also completed open‑market sales totaling 17,711 shares at weighted average prices of about $81.04 and $82.14 per share. One reported sale left her with 9,531 shares held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 11,000 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 18,368 | $0.00 | $0.00 |
| Exercise | Common Stock | 11,000 | $34.96 | $385K |
| Exercise | Common Stock | 18,368 | $49.39 | $907K |
| Exercise Price or Tax Liability | Common Stock | 4,661 | $82.50 | $385K |
| Exercise Price or Tax Liability | Common Stock | 10,996 | $82.50 | $907K |
| Sale | Common Stock | 13,375 | $81.0385 | $1.08M |
| Sale | Common Stock | 4,336 | $82.14 | $356K |
Footnotes (5)
- F1. The Reporting Person exercised a stock option to purchase 11,000 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 4,661 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.
- F2. The Reporting Person exercised a stock option to purchase 18,368 shares of the Issuer's Common Stock for $49.39 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 10,996 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F4. The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in two equal annual installments thereafter.
- F5. The option shares are fully vested.
Key Figures
Key Terms
open-market sale financial
tax-withholding disposition financial
cashless basis financial
stock option financial
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Anterix (ATEX) executive Gena Ashe do in this Form 4 filing?
How many Anterix (ATEX) stock options did Gena Ashe exercise?
What Anterix (ATEX) holdings remain for Gena Ashe after these transactions?
At what prices were Gena Ashe’s Anterix (ATEX) transactions executed?
AI-generated analysis. How Rhea-AI works. Not financial advice.